Crossmark

Artificial Intelligence and the Future of the Drug Safety Professional

Crossref DOI link: https://doi.org/10.1007/s40264-018-0746-z

Published Online: 2018-10-20

Published Print: 2019-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Danysz, Karolina https://orcid.org/0000-0001-8605-164X
Cicirello, Salvatore

Mingle, Edward

Assuncao, Bruno

Tetarenko, Niki

Mockute, Ruta

Abatemarco, Danielle

Widdowson, Mark

Desai, Sameen
License Information

Text and Data Mining valid from 2018-10-20
More Information

Article History

First Online: 20 October 2018

Compliance with Ethical Standards

:

: Karolina Danysz is a paid employee of Celgene International Sàrl, Switzerland, working as a Senior Drug Safety Innovation Specialist. Salvatore Cicirello, Edward Mingle, Bruno Assuncao, Niki Tetarenko, Ruta Mockute, Danielle Abatemarco, Mark Widdowson, and Sameen Desai are employees of Celgene Corporation. All authors and those interviewed as part of this research were employees of Celgene Corporation at the time this paper was written and have no other potential conflicts of interest that are directly relevant to the contents.

: No funding was used to assist in the preparation of this article.